Therapy of Schizoaffective Disorder and Paranoid Schizophrenia with Episodic Course
Background. The use of atypical antipsychotics in schizophrenia contributes to the reduction of psychotic, affective, negative and cognitive disorders.Aims. To evaluate the effectiveness of ziprasidone therapy in patients with schizoaffective disorder and paranoid schizophrenia with episodic course....
Saved in:
Main Authors: | L. A. Ivanova, O. P. Vorsina, T. A. Eliseeva, K. A. Frolovа, E. V. Sapozhnikova |
---|---|
Format: | article |
Language: | RU |
Published: |
Scientific Сentre for Family Health and Human Reproduction Problems
2019
|
Subjects: | |
Online Access: | https://doaj.org/article/70ad0fb5d56344a5be659d884e219320 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Initiating/maintaining long-acting injectable antipsychotics in schizophrenia/schizoaffective or bipolar disorder – expert consensus survey part 2
by: Sajatovic M, et al.
Published: (2018) -
Patterns of Thyroid Hormone Prescription in Patients with Bipolar or Schizoaffective Disorder: Findings from the LiSIE Retrospective Cohort Study
by: Ingrid Lieber, et al.
Published: (2021) -
Immunoinflammatory Profile in Patients with Episodic and Continuous Paranoid Schizophrenia
by: Irina K. Malashenkova, et al.
Published: (2021) -
Predictive Utility of Body Mass Index for Metabolic Syndrome Among Patients with Schizophrenia in Japan
by: Sugawara N, et al.
Published: (2020) -
Psychopharmacotherapy of Suicidal Behavior in Schizophrenia and Schizophrenic Spectrum Disorders
by: L. A. Ivanova
Published: (2020)